U.S. Imposes Trade Restrictions on Chinese Genomics Firm BGI

The U.S. government has announced trade restrictions targeting BGI, a leading Chinese genomics company. This decision comes amid allegations by U.S. officials that BGI is linked to forced labor and the abuse of minority groups. The restrictions will block shipments from BGI to the United States.

Originally published by nyt